Desouza Errol B Insider Trades

Insider Trading History

Track insider trading activity for Desouza Errol B. See latest buy and sell transactions across all companies.

Holdings

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price

Insider Trades History

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
Alector
Alector ALEC
Director
Holding Value $128k 69,950 shares
Last Trade
Jun 11, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$15.4k 9,450 shares
$1.63
$1.83
Royalty Pharma plc
Royalty Pharma plc RPRX
Director
Holding Value $4.5M 81,352 shares
Last Trade
May 13, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$250k 7,614 shares
$32.82
$55.34
Royalty Pharma plc
Royalty Pharma plc RPRX
Director
Holding Value $4.08M 73,738 shares
Last Trade
Jun 07, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$255k 9,293 shares
$27.46
$55.34
Alector
Alector ALEC
Director
Holding Value $75.5k 41,250 shares
Last Trade
Mar 19, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$120k 19,420 shares
$6.20
$1.83
Royalty Pharma plc
Royalty Pharma plc RPRX
Director
Holding Value $3.57M 64,445 shares
Last Trade
Jun 23, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$240k 7,747 shares
$30.95
$55.34
Royalty Pharma plc
Royalty Pharma plc RPRX
Director
Holding Value $3.14M 56,698 shares
Last Trade
Jun 24, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$273k 6,328 shares
$43.20
$55.34
Cyclerion Therapeutics
Cyclerion Therapeutics CYCN
Director
Holding Value $65.4k 20,000 shares
Last Trade
Jun 14, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$4.24M 20,000 shares
$212.04
$3.27
Royalty Pharma plc
Royalty Pharma plc RPRX
Director
Holding Value $2.79M 50,370 shares
Last Trade
Jun 25, 2021 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$244k 5,726 shares
$42.58
$55.34
Cyclerion Therapeutics
Cyclerion Therapeutics CYCN
Director
Holding Value $32.7k 10,000 shares
Last Trade
Jun 24, 2021 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$15.9M 10,000 shares
$1,588.00
$3.27
Royalty Pharma plc
Royalty Pharma plc RPRX
Director
Holding Value $2.47M 44,644 shares
Last Trade
Jun 18, 2020 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$454k 8,929 shares
$50.90
$55.34
Royalty Pharma plc
Royalty Pharma plc RPRX
Director
Holding Value $2.98M 53,915 shares
Last Trade
Jun 15, 2020 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
No data
No data
$55.34
Royalty Pharma plc
Royalty Pharma plc RPRX
Director
Holding Value $0 0 shares
Last Trade
Jun 15, 2020 Sale
No data
No data
$55.34
Royalty Pharma plc
Royalty Pharma plc RPRX
Director
Holding Value $1.98M 35,715 shares
Last Trade
Jun 15, 2020 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
No data
No data
$55.34
Albireo Pharma
Albireo Pharma ALBO
CEO
Holding Value $8.96M 202,885 shares
Last Trade
Sep 30, 2015 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$57.7k 131,128 shares
$0.44
$44.15
Albireo Pharma
Albireo Pharma ALBO
CEO
Holding Value $7.04M 159,416 shares
Last Trade
Sep 30, 2015 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$19.1k 43,469 shares
$0.44
$44.15
Albireo Pharma
Albireo Pharma ALBO
CEO
Holding Value $9.93M 225,000 shares
Last Trade
Dec 19, 2014 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$313k 225,000 shares
$1.39
$44.15
Albireo Pharma
Albireo Pharma ALBO
CEO
Holding Value $5.79M 131,128 shares
Last Trade
Nov 11, 2014 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$206k 131,128 shares
$1.57
$44.15
Albireo Pharma
Albireo Pharma ALBO
CEO
Holding Value $3.25M 73,517 shares
Last Trade
Mar 12, 2014 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$18.4k 5,625 shares
$3.27
$44.15
Albireo Pharma
Albireo Pharma ALBO
CEO
Holding Value $3.17M 71,757 shares
Last Trade
Mar 12, 2014 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$5.76k 1,760 shares
$3.27
$44.15
Albireo Pharma
Albireo Pharma ALBO
CEO
Holding Value $0 0 shares
Last Trade
Mar 12, 2014 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$18.4k 5,625 shares
$3.27
$44.15

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up